X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6) 6
oncology (4) 4
cancer (3) 3
cancer therapies (3) 3
cervical cancer (3) 3
clinical medicine (3) 3
humans (3) 3
ovarian cancer (3) 3
research (3) 3
age (2) 2
breast cancer (2) 2
cancer and oncology (2) 2
cancer och onkologi (2) 2
care and treatment (2) 2
cervical cancer; guidelines; management; staging; follow-up (2) 2
female (2) 2
follow-up (2) 2
gene mutations (2) 2
guidelines (2) 2
health risk assessment (2) 2
klinisk medicin (2) 2
management (2) 2
medical and health sciences (2) 2
medical screening (2) 2
medicin och hälsovetenskap (2) 2
mutation (2) 2
patients (2) 2
pregnancy (2) 2
radiotherapy (2) 2
staging (2) 2
trade and professional associations (2) 2
womens health (2) 2
1326 (1) 1
1506 (1) 1
1694 (1) 1
administration, intravenous (1) 1
administration, oral (1) 1
adult (1) 1
aged (1) 1
animals (1) 1
anisotropy (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
benefits (1) 1
benign (1) 1
biological sciences (1) 1
biomechanics (1) 1
biopolymers - chemistry (1) 1
brca1 protein (1) 1
brca1 protein - genetics (1) 1
brca2 protein (1) 1
brca2 protein - genetics (1) 1
breast-cancer (1) 1
carboplatin - administration & dosage (1) 1
carcinoma (1) 1
carriers (1) 1
cell line, tumor (1) 1
cell physiology (1) 1
cell research (1) 1
cell-migration (1) 1
cervix (1) 1
chemotherapy (1) 1
cisplatin (1) 1
collagen (1) 1
collagen gels (1) 1
collagen type i - chemistry (1) 1
combination (1) 1
computer simulation (1) 1
computer-generated environments (1) 1
consensus (1) 1
consortia (1) 1
deoxyribonucleic acid--dna (1) 1
disease progression (1) 1
disease-free survival (1) 1
diseases (1) 1
drug administration schedule (1) 1
drug facts box (1) 1
elasticity (1) 1
endometrial cancer (1) 1
enzyme inhibitors - administration & dosage (1) 1
enzyme inhibitors - adverse effects (1) 1
europe (1) 1
evidence based practice (1) 1
evidence-based practice (1) 1
extracellular matrix - metabolism (1) 1
extracellular-matrix (1) 1
fertility (1) 1
fiber network (1) 1
fiber networks (1) 1
fibroblasts - metabolism (1) 1
finite element method (1) 1
gels - chemistry (1) 1
genetic aspects (1) 1
genital tract (1) 1
group dynamics (1) 1
gynecological cancers (1) 1
gynecology (1) 1
gynecology - methods (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 87 - 97
Summary Background The poly(ADP-ribose) polymerase inhibitor olaparib has shown antitumour activity in patients with platinum-sensitive, recurrent, high-grade... 
Hematology, Oncology and Palliative Medicine | LIPOSOMAL DOXORUBICIN | MULTICENTER | INHIBITION | SOLID TUMORS | CISPLATIN | ONCOLOGY | POLYMERASE | OPEN-LABEL | COMBINATION | CARCINOMA | MAINTENANCE THERAPY | Piperazines - administration & dosage | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - administration & dosage | Ovarian Neoplasms - mortality | Molecular Targeted Therapy | Enzyme Inhibitors - administration & dosage | Ovarian Neoplasms - genetics | Young Adult | Neoplasm Grading | Time Factors | Antineoplastic Agents - adverse effects | Adult | Female | Neoplasms, Cystic, Mucinous, and Serous - drug therapy | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Enzyme Inhibitors - adverse effects | Neoplasms, Cystic, Mucinous, and Serous - pathology | Phthalazines - administration & dosage | Drug Administration Schedule | Administration, Oral | Neoplasm Recurrence, Local | Carboplatin - administration & dosage | Neoplasms, Cystic, Mucinous, and Serous - enzymology | Treatment Outcome | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors | Ovarian Neoplasms - enzymology | BRCA1 Protein - genetics | Disease-Free Survival | Administration, Intravenous | Poly(ADP-ribose) Polymerases - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Mutation | BRCA2 Protein - genetics | Neoplasms, Cystic, Mucinous, and Serous - mortality | Phthalazines - adverse effects | Relapse | Chemotherapy | Hospitals | Gene mutations | Sugars | Diseases | Cancer | Monosaccharides | Ovarian cancer
Journal Article
Virchows Archiv, ISSN 0945-6317, 6/2018, Volume 472, Issue 6, pp. 919 - 936
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 06/2018, Volume 127, Issue 3, pp. 404 - 416
Journal Article
Journal of Computing and Information Technology, ISSN 1330-1136, 2008, Volume 16, Issue 3, p. 209
Modelling of patient knee joint from the MRI data and simulating its kinematics is presented. A flexion of the femur with respect to the tibia from... 
Finite element method | Knee | Knee joint | Usage | Computer-generated environments | Computer simulation | Magnetic resonance imaging | Models | Methods
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.